Co-Authors
This is a "connection" page, showing publications co-authored by Anwar Hashem and Abdullah Algaissi.
Connection Strength
3.415
-
SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients. Sci Rep. 2020 10 06; 10(1):16561.
Score: 0.907
-
Evaluation of MERS-CoV Neutralizing Antibodies in Sera Using Live Virus Microneutralization Assay. Methods Mol Biol. 2020; 2099:107-116.
Score: 0.860
-
Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1. Vaccines (Basel). 2021 Aug 04; 9(8).
Score: 0.240
-
Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia. Viruses. 2021 07 20; 13(7).
Score: 0.239
-
Performance of Commercially Available Rapid Serological Assays for the Detection of SARS-CoV-2 Antibodies. Pathogens. 2020 Dec 19; 9(12).
Score: 0.230
-
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients. Viruses. 2020 12 04; 12(12).
Score: 0.229
-
Evaluation of Neutralizing Antibodies Against Highly Pathogenic Coronaviruses: A Detailed Protocol for a Rapid Evaluation of Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudovirus-Based Assay. Front Microbiol. 2020; 11:2020.
Score: 0.225
-
Quantification of the Middle East Respiratory Syndrome-Coronavirus RNA in Tissues by Quantitative Real-Time RT-PCR. Methods Mol Biol. 2020; 2099:99-106.
Score: 0.215
-
A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model. J Infect Dis. 2019 10 08; 220(10):1558-1567.
Score: 0.212
-
Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia. J Infect Public Health. 2021 Jul; 14(7):832-838.
Score: 0.059